Sort   by:  
 Page size 
UnknownPrenatal depression and 5-HTTLPR interact to predict dysregulation from 3 to 36 months--a differential susceptibility model.
Not available
S-EPMC5398894 | biostudies-literature
UnknownStatus of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes.
Not available
S-EPMC4816597 | biostudies-literature
UnknownImplementation of a best-practice model of care for cognitive impairment and dementia for first nations peoples attending primary care in Australia: a stepped-wedge cluster-randomised trial.
Not available
S-EPMC12002872 | biostudies-literature
UnknownAssociation of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
Not available
S-EPMC8100913 | biostudies-literature
UnknownMethotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Not available
S-EPMC4486345 | biostudies-literature
UnknownVariants in TCF20 in neurodevelopmental disability: description of 27 new patients and review of literature.
Not available
S-EPMC7171701 | biostudies-literature
UnknownTwo phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Not available
S-EPMC4159618 | biostudies-literature
UnknownNeuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis.
Not available
S-EPMC9325730 | biostudies-literature
UnknownAusTraits, a curated plant trait database for the Australian flora.
Not available
S-EPMC8484355 | biostudies-literature
UnknownOutcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Not available
S-EPMC2993160 | biostudies-literature
Sort   by:  
 Page size